Whip-LAMP: a novel LAMP assay for the detection of Trichuris muris-derived DNA in stool and urine samples in a murine experimental infection model

Autor: Pedro Fernández-Soto, Carlos Fernández-Medina, Susana Cruz-Fernández, Beatriz Crego-Vicente, Begoña Febrer-Sendra, Juan García-Bernalt Diego, Óscar Gorgojo-Galindo, Julio López-Abán, Belén Vicente Santiago, Antonio Muro Álvarez

Publikováno v: Parasites & Vectors, Vol 13, Iss 1, Pp 1-11 (2020)

Abstract Background Trichuris trichiura (human whipworm) infects an estimated 477 million individuals worldwide. In addition to T. trichiura, other Trichuris species can cause an uncommon zoonosis and a number of human cases have been reported. The d

Externí odkaz: https://doaj.org/article/77d538ae0a4f43478bdfbeaff7b97b2e

Avances en el desarrollo de nuevas vacunas contra Fasciola hepatica

Autor: Darío Perallón Mantas, Javier Sánchez Montejo, Antonio Muro Álvarez

Publikováno v: FarmaJournal. 8:49-57

a fasciolosis es una zoonosis provocada por el trematodo Fasciola hepatica que afecta ampliamente al sector ganadero. Sin embargo, aún no se ha desarrollado una vacuna eficaz para evitar el contagio de este parásito. En este trabajo se ha empleado

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54f5329b8c8db5926fb534fb6c515e54
https://doi.org/10.14201/fj2023814957

Whip-LAMP: a novel LAMP assay for the detection of Trichuris muris-derived DNA in stool and urine samples in a murine experimental infection model

Autor: Antonio Muro Álvarez, Carlos Fernández-Medina, Pedro Fernández-Soto, Begoña Febrer-Sendra, Beatriz Crego-Vicente, Juan García-Bernalt Diego, Susana Cruz-Fernández, Oscar Gorgojo-Galindo, Belén Vicente Santiago, Julio López-Abán

Publikováno v: Parasites & Vectors
Parasites & Vectors, Vol 13, Iss 1, Pp 1-11 (2020)

Background Trichuris trichiura (human whipworm) infects an estimated 477 million individuals worldwide. In addition to T. trichiura, other Trichuris species can cause an uncommon zoonosis and a number of human cases have been reported. The diagnosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::666d4e86aa78943fda66409ee4d2ee72
https://pubmed.ncbi.nlm.nih.gov/33160406

Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform

Autor: Anke L. Stuurman, Antonio Carmona, Jorne Biccler, Alexandre Descamps, Miriam Levi, Ulrike Baum, Ainara Mira-Iglesias, Stefania Bellino, Uy Hoang, Simon de Lusignan, Roberto Bonaiuti, Bruno Lina, Caterina Rizzo, Hanna Nohynek, Javier Díez-Domingo, DRIVE Study Contributors, Anca Cristina Drăgănescu, Oana Săndulescu, Daniela Piţigoi, Victor Daniel Miron, Anca Streinu-Cercel, Anuţa Bilaşco, Adrian Streinu-Cercel, Dragoş Florea, Ovidiu Vlaicu, Simona Paraschiv, Leontina Bănică, Dan Oţelea, Monika Redlberger-Fritz, Eva Geringer, Amparo López-Bernus, Ana Haro Perez, Nieves Gutierrez Zufiaurre, Cristina Carbonell Muñoz, Miguel Marcos Martin, Muñoz Juan Luis Bellido, Isabel Gil Rodríguez, Antonio Muro Alvarez, Moncef Belhassen Garcia, Giancarlo Icardi, Stefano Mosca, Donatella Panatto, Emanuele Montomoli, Silvana Castaldi, Andrea Orsi, Alexander Domnich, Maria Chironna, Daniela Loconsole, Ilaria Manini, Christian Napoli, Alessandra Torsello, Elena Pariani, and Piero Luigi Lai, Susana Otero-Romero, Andrés Antón Pagarolas, Cristina Andrés, Ingrid Carbonés, Oleguer Pares, Mar Fornaguera, Anna Oller, Xavier Salgado, Patricia Tejerina, Cristina Martinez, Alejandro Orrico-Sánchez, F. Xavier López-Labrador, Beatriz Mengual-Chuliá, Judit Sánchez Soler, María Jinglei Casanova Palomino, Juan Mollar-Maseres, Miguel Tortajada-Girbés, Noelia Rodríguez-Blanco, Mario Carballido-Fernández, Raquel Andreu Ivorra, Àngels Sierra Fortuny, Beatriz Segura Segura, Cristina Mingot Ureta, Sagrario Corrales Díaz-Flores, Ángela Sánchez Pla, María Dolores Tirado Balaguer, Juan Alberola, José Miguel Nogueira, Juan J Camarena, Francisco Arjona-Zaragozí, Maruan Shalabi Benavent, José Luis López-Hontangas, María Dolores Gómez, Alejandro Martín-Quirós, Carlos Cañada Illana, Emilio Cendejas, Irma Casas García, Guillermo Mena Pinilla, María Esteve Pardo, Lola Álamo Junquera, Cristina Casañ, Sandra Fernandez Morodo, Agueda Hernández, Pere-Joan Cardona, Marta Segura, Andreu C. Pelegrin, Sara González-Gómez, Verónica Saludes, Elisa Martró, Valtýr Stefánsson Thors, Kristín L. Björnsdóttir, Liem Luong, Zineb Lesieur, Yacine Saidi, Rebecca Bauer, Christine Pereira, Philippe Vanhems, Fabrice Lainé, Florence Galtier, Xavier Duval, Christine Durier, Paolo Bonanni, Alfredo Vannacci, Claudia Ravaldi

Publikováno v: Frontiers in Public Health, Vol 11 (2023)

IntroductionDevelopment of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public–private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public

Externí odkaz: https://doaj.org/article/75fb3f72a3704f36bf12c2869d3a6c12